Cite

HARVARD Citation

    Sluiter, R. et al. (2019). Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease. Journal of Crohn's and colitis. pp. 838-845. [Online]. 
  
Back to record